全文获取类型
收费全文 | 6544篇 |
免费 | 512篇 |
国内免费 | 403篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 154篇 |
妇产科学 | 139篇 |
基础医学 | 719篇 |
口腔科学 | 111篇 |
临床医学 | 770篇 |
内科学 | 1259篇 |
皮肤病学 | 69篇 |
神经病学 | 253篇 |
特种医学 | 393篇 |
外国民族医学 | 2篇 |
外科学 | 630篇 |
综合类 | 951篇 |
预防医学 | 393篇 |
眼科学 | 143篇 |
药学 | 549篇 |
1篇 | |
中国医学 | 298篇 |
肿瘤学 | 555篇 |
出版年
2024年 | 18篇 |
2023年 | 60篇 |
2022年 | 182篇 |
2021年 | 223篇 |
2020年 | 181篇 |
2019年 | 201篇 |
2018年 | 180篇 |
2017年 | 159篇 |
2016年 | 176篇 |
2015年 | 286篇 |
2014年 | 348篇 |
2013年 | 287篇 |
2012年 | 447篇 |
2011年 | 439篇 |
2010年 | 331篇 |
2009年 | 286篇 |
2008年 | 294篇 |
2007年 | 368篇 |
2006年 | 331篇 |
2005年 | 332篇 |
2004年 | 190篇 |
2003年 | 199篇 |
2002年 | 192篇 |
2001年 | 172篇 |
2000年 | 153篇 |
1999年 | 155篇 |
1998年 | 154篇 |
1997年 | 154篇 |
1996年 | 105篇 |
1995年 | 92篇 |
1994年 | 96篇 |
1993年 | 71篇 |
1992年 | 58篇 |
1991年 | 50篇 |
1990年 | 50篇 |
1989年 | 60篇 |
1988年 | 74篇 |
1987年 | 53篇 |
1986年 | 39篇 |
1985年 | 38篇 |
1984年 | 27篇 |
1983年 | 15篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 10篇 |
1977年 | 17篇 |
1976年 | 15篇 |
1975年 | 15篇 |
排序方式: 共有7459条查询结果,搜索用时 15 毫秒
1.
Ouédraogo Dieu-Donné Tiendrébéogo Wendlassida Joelle Stéphanie Kaboré Fulgence Ntsiba Honoré 《Clinical rheumatology》2020,39(7):2069-2075
Clinical Rheumatology - Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China.... 相似文献
2.
3.
不同病理类型原发性甲状旁腺功能亢进症临床表现的比较分析 总被引:2,自引:0,他引:2
目的 分析不同病理类型甲状旁腺功能亢进(PHPT)的临床表现特点。方法 回顾性分析1958-2005年北京协和医院收治经手术病理证实的280例PHPT患者的临床资料。按病理类型分为甲状旁腺腺瘤组208例,甲状旁腺增生组52例及甲状旁腺腺癌组20例。结果 腺癌组中男性高于另外2组(P〈0.05)。增生及腺癌组中骨畸形、骨软化比例较低,增生组骨吸收、病理性骨折比例低于腺瘤组;胃肠道症状、多饮多尿及泌尿系统病变在腺癌组中高于另外2组(P均〈0.05)。血总钙(TCa)、血游离钙离子(ICa)及24h尿Ca在腺癌组显著高于腺瘤组及增生组(P均〈0.01),在腺瘤组与增生组间差异无统计学意义(P〉0.05)。出现高钙危象的比例在腺癌组显著高于另外2组(P〈0.01)。腺癌组病灶重量高于增生组,腺瘤组病灶直径小于增生组(P均〈0.05)。结论 在本组病例中,腺癌组男性比例较高,泌尿系统病变更为多见,出现高钙危象的比例显著增高,术后复发的比例较高。增生组骨骼系统病变相对较轻,其病变甲状旁腺重量低于腺癌与腺瘤组。 相似文献
4.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
5.
6.
The limitations of current methods of measuring bilirubin are well established and relate to the broad dynamic range and inability of the technique to determine different but structurally similar bilirubin species. New instrumentation and methodology circumvent these limitations, and clinical studies are beginning to reveal their increased diagnostic usefulness. Nevertheless, in several clinical situations, for example, the prediction of kernicterus, better bilirubin determinations may not eliminate the controversy surrounding appropriate therapeutic interventions. 相似文献
7.
Bone morphogenetic protein (BMP) was isolated from the bone matrix of swine and partially purified by means of differential precipitation and molecular sieve chromatography. The molecular weight of BMP estimated by SDS-gel electrophoresis was 19,000 dalton. Bioassay by implanting two milligrams of BMP fraction into thigh muscles of mice resulted in bone formation in 100% of the experimental animals.
相似文献
8.
地尔硫卓联合地高辛治疗心力衰竭并慢性快速房颤分析 总被引:3,自引:1,他引:2
目的观察地尔硫卓联合小剂量地高辛对心力衰竭并慢性快速房颤患者血压、心室率和心功能的影响。方法 :心功能Ⅱ~Ⅲ级慢性房颤患者 10 6例 ,随机分为二组 ,对照组 5 0例 ,单用地高辛 ,治疗组 5 6例 ,地尔硫卓与地高辛联用 ,其余治疗二组相同 ,7~ 10d为一疗程 ,观察治疗前后血压、心率、左室射血分数 (LVEF)、心输出量 (CO)。结果 :治疗组较对照组心室率明显下降 ,控制满意 ,血压、LVEF及CO变化二组相似。结论 :地尔硫卓联合小剂量地高辛治疗心衰并慢性快速房颤患者心室率较单用地高辛效果更好 ,且较为安全。 相似文献
9.
海藻、甘草及其相伍用对小鼠肝药酶的影响 总被引:5,自引:0,他引:5
目的:研究海藻、甘草单煎液及其不同比例合煎,单煎后混合液以及单体A、B;C、D、E对小鼠肝药酶的影响。方法:取小鼠随机分组,分别ig给药,qd,连续4d后禁食20h,处死取肝脏,称重后制成匀浆,紫外分光光度计于450nm,490nm波长下测其光密度值,计算肝匀浆中细胞色素P-450的含量。结果:甘草、甘草与海藻合煎液及单体A,B,C,D,E均能显著提高小鼠肝匀浆中细胞色素P-450的含量,而海藻,甘草与海藻单煎后混合液未能提高小鼠肝心浆中的细胞色素P-450的含量。结论:甘草,甘草与海藻合煎液及单体,A,B,C,D,E均能显著提高小鼠肝匀浆中细胞色素P-450的含量,对肝药酶有诱导作用。 相似文献
10.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献